Atlas Trials

A Study of 2 Doses of Tetravalent Dengue Vaccine (TDV) in Infants and Toddlers

Clinical trial NCT06665035 · RECRUITING

Trial details

NCT number
NCT06665035
Sponsor
Takeda
Status
RECRUITING
Phase
Phase 3
Study type
INTERVENTIONAL
Dengue Fever
Start date
2025-06-16
Primary completion
2030-03-03
Enrollment
212

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.